From StopAfib.org - For Afib Patients, By Afib Patients
There was an update today on the long-awaited FDA status of Atritech’s WATCHMAN® device. If approved, it would provide an alternative to taking Coumadin or warfarin to prevent strokes for those with atrial fibrillation. Here are some quotes from the press release. Minneapolis (March 18, 2010) — Atritech, Inc., an emerging medical device company, announced [...]
Genetic tests that show high or low sensitivity to blood thinner (anticoagulant) drugs like warfarin (Coumadin) not only improve dosing accuracy but also reduce hospitalization by 31%, according to a new study just presented at the American College of Cardiology scientific sessions. Coumadin is often prescribed for people who have afib to prevent blood clots [...]
A new study just presented at the American College of Cardiology scientific sessions found psoriasis to be a significant and independent risk factor for atrial fibrillation (AF) and a stroke risk factor, too. Mild psoriasis increases afib risk by 22% while moderate-to-severe psoriasis raises afib risk by 51%. This chronic inflammatory condition also raises other [...]
There is a lot of news coming out of the American College of Cardiology annual meetings going on currently in Orlando. One such story, about the Watchman device trial, is particularly important to those with afib who are concerned about blood clots and stroke. Read more at: Watchman Device as Alternative to Warfarin or Coumadin
